Tetraphase Pharmaceuticals to Present at Upcoming Investor Conferences
02 April 2019 - 7:03AM
Business Wire
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a
biopharmaceutical company focused on developing and commercializing
novel tetracyclines to treat serious and life-threatening
conditions, today announced that senior management will present a
corporate overview at the H. C. Wainwright and Company Global Life
Sciences Conference on Monday, April 8, 2019 at 9:10 a.m. GMT at
the Grosvenor House JW Marriott Hotel in London, UK and at the 18th
Annual Needham Healthcare Conference on Wednesday, April 10, 2019
at 2:50 p.m. ET at the Westin Grand Central Hotel in New York
City.
Live audio webcasts of both presentations will be available on
the Company’s website at
https://tphase.gcs-web.com/events-presentations. The archived
presentation will be available for 30 days.
About Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc., is a biopharmaceutical company
using its proprietary chemistry technology to create novel
tetracyclines for serious and life-threatening conditions,
including bacterial infections caused by many of the
multidrug-resistant bacteria highlighted as urgent public health
threats by the World Health Organization and the Centers for
Disease Control and Prevention. The Company has created more than
3,000 novel tetracycline compounds using its proprietary technology
platform. Tetraphase's lead product XERAVATM is approved for the
treatment of complicated intra-abdominal infections by the U.S.
Food and Drug Administration and the European Medicines Agency. The
Company’s pipeline also includes TP-271 and TP-6076, which are in
Phase 1 clinical trials and TP-2846 which is in preclinical testing
for acute myeloid leukemia. Please visit www.tphase.com for more
company information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190401005629/en/
Jennifer Vierajviera@tphase.com617-600-7040
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Apr 2024 to May 2024
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Tetraphase Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Tetraphase Pharmaceuticals, Inc. News Articles